West Pharmaceutical Services Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $208.3M | $2.33B | $667.7M |
| Jun 2022 | $207.8M | $2.42B | $718.5M |
| Sep 2022 | $207.2M | $2.47B | $729.0M |
| Dec 2022 | $206.7M | $2.68B | $894.3M |
| Mar 2023 | $206.1M | $2.78B | $886.3M |
| Jun 2023 | $205.6M | $2.75B | $796.3M |
| Sep 2023 | $152.1M | $2.87B | $898.6M |
| Dec 2023 | $72.8M | $2.88B | $853.9M |
| Mar 2024 | $72.8M | $2.68B | $601.8M |
| Jun 2024 | $72.9M | $2.58B | $446.2M |
| Sep 2024 | $202.6M | $2.75B | $490.9M |
| Dec 2024 | $202.6M | $2.68B | $484.6M |
| Mar 2025 | $202.6M | $2.68B | $404.2M |
| Jun 2025 | $202.6M | $2.93B | $509.7M |
| Sep 2025 | $202.7M | $3.05B | $628.5M |
| Dec 2025 | $202.8M | $3.18B | $791.3M |
| Mar 2026 | $202.8M | $2.99B | $521.4M |
| Jun 2026 | $202.9M | $2.99B | $435.8M |